iSBTc-FDA-NCI Workshop on Prognostic and Predictive Immunologic Biomarkers in Cancer

October 28, 2009
Gaylord National Hotel and Convention Center
Washington, D.C.

 

Workshop Organizers 

Lisa H. Butterfield, PhD
University of Pittsburgh

Mary (Nora) Disis, MD
University of Washington

Samir Khleif, MD
National Cancer Institute

       

Francesco Marincola, MD
National Institutes of Health

Magdalena Thurin, PhD
National Cancer Institute

     

 

Faculty

Cedrik M. Britten, MD
Johannes Gutenberg University

Lisa H. Butterfield, PhD
University of Pittsburgh

Damien Chaussabel, PhD
Baylor Institute for Immunology Research

Mark M. Davis, PhD
Howard Hughes Medical Institute / Stanford University School of Medicine

Madhav Dhodapkar, MD
Yale University

Mary (Nora) Disis, MD
University of Washington

Bernard A. Fox, PhD
Earle A. Chiles Research Institute

James W. Jacobson, PhD
Cancer Diagnosis Program, DCTD, NCI

Sylvia Janetzki, MD
ZellNet Consulting

Samir Khleif, MD
National Cancer Institute

Steven Kozlowski, MD
Food and Drug Administration, Office of Biotechnology Products

Alan L. Landay, PhD
Rush University Medical Center

Peter P. Lee, MD
Stanford University

Lance Liotta, MD, PhD
George Mason University

Holden T. Maecker, PhD
Stanford University Medical Center

Vernon C. Maino, PhD
BD Biosciences

Anatoli M. Malyguine, MD, PhD
SAIC-Frederick, Inc., NCI-Frederick

Francesco Marincola, MD
National Institutes of Health

Shawnmarie Mayard-Chung, PhD, JD
National Institutes of Health - Office of the Director, OPSA Public-Private Partnerships Program

A. Karolina Palucka, MD, PhD
Baylor Instiute for Immunology Research

Douglas M. Potter, PhD
University of Pittsburgh

Licia Rivoltini, MD
Fondazione IRCCS Istituto Nazionale dei Tumori

Lupe G. Salazar, MD
University of Washington

Rafick-Pierre Sékaly, PhD
University of Montreal; VGTI Florida

David Stroncek, MD
Cell Processing, DTM, CC, National Institutes of Health

Hideaki Tahara, MD, PhD
University of Tokyo

Giorgio Trinchieri, MD
National Cancer Institute

Theresa L. Whiteside, PhD
University of Pittsburgh Cancer Institute